Буковинський Державний Медичний Університет Моз України
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Буковинський Державний Медичний Університет Моз УкраїниfiledCriticalБуковинський Державний Медичний Університет Моз України
Priority to UAU201407619UpriorityCriticalpatent/UA95830U/en
Publication of UA95830UpublicationCriticalpatent/UA95830U/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
A method for treating chronic obstructive pulmonary disease associated with metabolic syndrome by basic therapy. It is additionally prescribed to administer S(-)amlodipine besylate at a dose of 2.5 mg and atorvastatin calcium at a dose of 10 mg, as a combined preparation "Amlostat" (Kusum Pharm, Ukraine), for six months.
UAU201407619U2014-07-072014-07-07Method for treating chronic obstructive pulmonary disease associated with metabolic syndrome
UA95830U
(en)
APPLICATION OF THE PHARMACEUTICAL COMPOSITION BASED ON THE SALT OF QUATERNARY PHOSPHONY AND SUBSTITUTED DINITROBENZOFUROXAN FOR THE TREATMENT OF Pyroplasmosis in Dogs and the Method of Treatment